Nabriva Therapeutics (NASDAQ:NBRV) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
Nabriva Therapeutics beat estimated earnings by 10.0%, reporting an EPS of $-0.18 versus an estimate of $-0.2.
Revenue was up $948 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.01 which was followed by a 10.32% drop in the share price the next day.
Here’s a look at Nabriva Therapeutics’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.19 | -0.19 | -0.24 | -0.35 |
| EPS Actual | -0.20 | -0.24 | -0.21 | -0.29 |
| Revenue Estimate | 9.57M | 10.10M | 9.50M | 5.99M |
| Revenue Actual | 8.02M | 9.26M | 8.86M | 8.24M |
To track all earnings releases for Nabriva Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
